510(k) Report

510(k) · Cleared

Cleared

Avance Solo Negative Pressure Wound Therapy (NPWT) System

K203369510(k) TraditionalCleared Jul 1, 2021227-day reviewClass II21 CFR 878.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Molnlycke Health Care Us, LLC · OMP Negative Pressure Wound Therapy Powered Suction Pump

Cleared on Jul 1, 2021 as substantially equivalent to K163387 (Smith & Nephew Medical Limited, 2017) and 1 other predicate after a 227-day review. Its family tree reaches back 10 generations to 1995.

Decided
Jul 1, 2021
Review
227 days
Class
Class II
Product code
OMP
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K945062 (1995). 26 ancestors in all, the oldest K933902 (1994). No later device cites it as a predicate yet.

  1. Root · 10 generations backK945062 VacplusKinetic Concepts, Inc. · 1995
  2. 6 generations between
  3. 3 generations backK112127 Pico Single Use Negative Pressure Wound Therapy SystemSmith & Nephew, Inc. · 2012
  4. 2 generations backK151436 PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical, Ltd. · 2016
  5. 1 generation backK163387 PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical Limited · 2017
  6. This deviceK203369 Avance Solo Negative Pressure Wound Therapy (NPWT) SystemMolnlycke Health Care Us, LLC · 2021
Show all 10 generations
  1. Root · 10 generations backK945062 VacplusKinetic Concepts, Inc. · 1995
  2. 9 generations backK042134 Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated · 2004 · Recalled
  3. 8 generations backK052456 Modification to Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated · 2005
  4. 7 generations backK061919 Versatile 1 Ezcare Wound Vacuum SystemBlue Sky Medical Group Incorporated · 2007 · Recalled
  5. 6 generations backK082426 Renasys EZSmith & Nephew, Inc. · 2008 · Recalled
  6. 5 generations backK083375 Renasys GO Negative Pressure Wound TherapySmith & Nephew, Inc. · 2009 · Recalled
  7. 4 generations backK111170 PICOSmith & Nephew, Inc. · 2011
  8. 3 generations backK112127 Pico Single Use Negative Pressure Wound Therapy SystemSmith & Nephew, Inc. · 2012
  9. 2 generations backK151436 PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical, Ltd. · 2016
  10. 1 generation backK163387 PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical Limited · 2017
  11. This deviceK203369 Avance Solo Negative Pressure Wound Therapy (NPWT) SystemMolnlycke Health Care Us, LLC · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K945062VacplusKinetic Concepts, Inc.1995—
−9K042134Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated20042
−8K052456Modification to Versatile 1 Wound Vacuum SystemBlue Sky Medical Group Incorporated2005—
−7K061919Versatile 1 Ezcare Wound Vacuum SystemBlue Sky Medical Group Incorporated20071
−6K082426Renasys EZSmith & Nephew, Inc.20084
−5K083375Renasys GO Negative Pressure Wound TherapySmith & Nephew, Inc.20092
−4K111170PICOSmith & Nephew, Inc.2011—
−3K112127Pico Single Use Negative Pressure Wound Therapy SystemSmith & Nephew, Inc.2012—
−2K151436PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical, Ltd.2016—
−1K163387PICO Single Use Negative Pressure Wound Therapy SystemSmith & Nephew Medical Limited2017—
0 (this device)K203369Avance Solo Negative Pressure Wound Therapy (NPWT) SystemMolnlycke Health Care Us, LLC2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199710
199910
200010
200210
200310
200510
200630
200720
200820
201010
201210
FIG. 1 — Lineage of K203369, 1995–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMP device

  1. #1 K260646 Renasys Edge (66803126)score 15.3 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K163387PICO Single Use Negative Pressure Wound Therapy System
Summary page 4
…Regulation Number: 21 CFR 878.4780 Product Code: OMP Predicate Device Name(s): PICO Single Use NPWT System (K163387) ActiVAC Therapy Unit (K120033) Description of Device: Avance Solo Negative Pressure Woun…
Smith & Nephew Medical Limited2017—
*K120033Activac Therapy Unit and Infovac Therapy Unit, Vac Ats Therapy Unit and Vac Freedom…
Summary page 4
…: OMP Predicate Device Name(s): PICO Single Use NPWT System (K163387) ActiVAC Therapy Unit (K120033) Description of Device: Avance Solo Negative Pressure Wound Therapy (NPWT) System consists of Avance Solo Pump, Avance Solo Cani…
Kci USA, Inc.2012—

Also cleared against K163387: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 6 companies; a new generation was cleared every 1.6 years on median.
  • 10 of the 26 ancestors have a recall of any class.
  • 2 other devices also cite its predicate K163387.

How does its category compare?

All OMP devices

OMP Negative Pressure Wound Therapy Powered Suction Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OMP

5in 2025

2007: 62008: 82009: 82010: 62011: 62012: 112013: 112014: 102015: 202016: 192017: 112018: 132019: 152020: 62021: 92022: 102023: 82024: 92025: 52026 (partial year): 9
2007high 20 (2015) · low 5 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMP

127in 2025

2007: 113 days median2008: 98 days median2009: 87 days median2010: 97 days median2011: 123 days median2012: 292 days median2013: 84 days median2014: 179 days median2015: 189 days median2016: 146 days median2017: 137 days median2018: 214 days median2019: 249 days median2020: 179 days median2021: 238 days median2022: 229 days median2023: 291 days median2024: 181 days median2025: 127 days median2026 (partial year): 141 days median
2007high 292 (2012) · low 84 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMP

2in 2024

2009: 72010: 32012: 12013: 22014: 42015: 12016: 22019: 12024: 2
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMP

140in 2025

2007: 12008: 12009: 792010: 802011: 1302012: 972013: 1692014: 2292015: 3782016: 3982017: 3682018: 4222019: 9942020: 3,6642021: 1,4222022: 2582023: 1432024: 1352025: 140
2007high 3,664 (2020) · low 1 (2007)2025

MAUDE reports naming product code OMP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611301
200889801
2009887779
2010697380
201161230130
201211292197
201311842169
2014101794229
2015201891378
2016191462398
2017111370368
2018132140422
2019152491994
2020617903,664
2021923801,422
2022102290258
202382910143
202491812135
202551270140
202691410—

What is it indicated for?

The Avance Solo NPWT System is indicated for patients who would benefit from wound management via the application of negative pressure wound therapy, particularly as the device may promote wound healing through the removal of exudate, infectious material.

Avance Solo NPWT System is indicated for removal of low to moderate amounts of exudates from chronic, acute, traumatic, subacute and dehisced wounds, ulcers (such as diabetic, venous or pressure), surgically closed incisions, flaps, and grafts.

Avance Solo NPWT System is intended for use by healthcare professionals for therapy on patients in healthcare facilities and home care settings.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K203369: Avance Solo Negative Pressure Wound Therapy (NPWT) System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203369

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026